Artículo especial
Cardiovascular abnormalities in special conditions of advanced cirrhosis.The circulatory adaptative changes to specific therapeutic procedures for the management of refractory ascites

https://doi.org/10.1157/13086820Get rights and content

Abstract

Advanced liver disease is characterized by decreased arterial blood pressure and peripheral vascular resistances, increased cardiac output and heart rate in the setting of a hyperdynamic circulatory pattern favoured by total blood volume expansion, circulatory overload and overactivity of the endogenous vasoactive systems. Reduced heart responses to stressful conditions such as changes in loading conditions of the heart in presence of further deterioration of liver function such as refractory ascites, hepatorenal syndrome, spontaneous bacterial peritonitis and bleeding esophageal varices have been recently identified and the knowledge of the cirrhotic cardiomyopathy syndrome has gained the dignity of a new clinical entity. Facing the availability of therapeutic interventions (paracentesis, transjugular intrahepatic portosystemic shunt, peritoneovenous shunt, orthotopic liver transplantation) currently employed to manage the life-threatening complications of the most advanced phases of cirrhotic disease, the knowledge of their impact on cardiovascular function is of paramount relevance.

References (61)

  • F. Acosta et al.

    Evaluation of cardiac function before and after liver transplantation

    Transplant Proc

    (1999)
  • M.G. González et al.

    Comparison of post-liver transplantation electrocardiographic alterations between cyclosporine- and tacrolimus-treated patients

    Transplant Proc

    (1999)
  • P. Burra et al.

    Myocardial perfusion scintigraphy in patients with liver cirrhosis evaluated for orthotopic liver transplantation

    Transplant Proc

    (2001)
  • V. Arroyo et al.

    Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club

    Hepatology

    (1996)
  • E. Quintero et al.

    Paracentesis versus diuretics in the treatment of cirrhotics with tense ascites

    Lancet

    (1985)
  • P. Ginès et al.

    Comparison of paracentesis and diuretics in the treatment of cirrhotics with tense ascites. Results of a randomized study

    Gastroenterology

    (1987)
  • L. Tito et al.

    Total paracentesis associated with intravenous albumin management of patients with cirrhosis and ascites

    Gastroenterology

    (1990)
  • M. Guazzi et al.

    Negative influences of ascites on the cardiac function of cirrhotic patients

    Am J Med

    (1975)
  • M. Pozzi et al.

    Time course of circulatory and humoral effects of rapid total paracentesis in cirrhotic patients with tense, refractory ascites

    Gastroenterology

    (1994)
  • M. Pozzi et al.

    Early effects of total paracentesis and albumin infusion on muscle sympathetic nerve activity in cirrhotic patients with tense ascites

    J Hepatol

    (1999)
  • A. Luca et al.

    Beneficial effects of intravenous albumin infusion on the hemodynamic and humoral changes after total paracentesis

    Hepatology

    (1995)
  • J. Sola-Vera et al.

    Randomized trial comparing albumin and saline in the prevention of paracentesis-induced circulatory dysfunction in cirrhotic patients with ascites

    Hepatology

    (2003)
  • R. Planas et al.

    Dextran-70 versus albumin as plasma expanders in cirrhotic patients with tense ascites treated with total paracentesis. Results of a randomized study

    Gastroenterology

    (1990)
  • A. Ginès et al.

    Randomized trial comparing albumin, dextran 70, and polygeline in cirrhotic patients with ascites treated by paracentesis

    Gastroenterology

    (1996)
  • F. Salerno

    Large-volume paracentesis and volume re-expansion: can synthetic plasma expanders safely replace albumin?

    J Hepatol

    (1992)
  • L. Ruiz-del-Árbol et al.

    Paracentesis-induced circulatory dysfunction: mechanism and effect on hepatic hemodynamics in cirrhosis

    Gastroenterology

    (1997)
  • M.C. Vila et al.

    Hemodynamic changes in patients developing effective hypovolemia after total paracentesis

    J Hepatol

    (1998)
  • D. Azoulay et al.

    Salvage transjugular intrahepatic portosystemic shunt for uncontrolled variceal bleeding in patients with decompensated cirrhosis

    J Hepatol

    (2001)
  • A.J. Stanley et al.

    Acute effects of transjugular intrahepatic portosystemic stent-shunt (TIPSS) procedure on renal blood flow and cardiopulmonary hemodynamics in cirrhosis

    Am J Gastroenterol

    (1998)
  • M. Merli et al.

    Modifications of cardiac function in cirrhotic patients treated with transjugular intrahepatic portosystemic shunt (TIPS)

    Am J Gastroenterol

    (2002)
  • Cited by (11)

    • Cirrhotic cardiomyopathy

      2022, Cardio-Hepatology: Connections Between Hepatic and Cardiovascular Disease
    • Cirrhotic cardiomyopathy: A specific entity

      2012, Annales de Cardiologie et d'Angeiologie
    • Frequency of Cardiomyopathy in Patients with Hepatic Cirrhosis

      2021, Journal of the Liaquat University of Medical and Health Sciences
    • Cardiopulmonary consequences of transjugular intrahepatic portosystemic shunts

      2011, Cardiovascular Diseases and Liver Transplantation
    View all citing articles on Scopus
    View full text